207 related articles for article (PubMed ID: 33795208)
1. Combination of Tagraxofusp and Azacitidine Is an Effective Option for Relapsed Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem-Cell Transplantation.
Wang SY; Thomassen K; Kurch L; Opitz S; Franke GN; Bach E; Platzbecker U; Kayser S
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e579-e582. PubMed ID: 33795208
[No Abstract] [Full Text] [Related]
2. Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.
Samhouri Y; Ursu S; Dutton N; Tanvi V; Fazal S
J Oncol Pharm Pract; 2021 Jun; 27(4):990-995. PubMed ID: 32847479
[TBL] [Abstract][Full Text] [Related]
3. Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm.
Piccini M; Loscocco GG; Gianfaldoni G; Grieco P; Palmieri G; Pilerci S; Scappini B; Bosi A
Ann Hematol; 2020 Apr; 99(4):907-909. PubMed ID: 32030448
[No Abstract] [Full Text] [Related]
4. Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: a case report and review of literature.
Sakashita K; Saito S; Yanagisawa R; Tanaka M; Yoshikawa K; Hirabayashi K; Tsukahara K; Motobayashi M; Nakazawa Y; Koike K
Pediatr Blood Cancer; 2013 Nov; 60(11):E140-2. PubMed ID: 23788509
[TBL] [Abstract][Full Text] [Related]
5. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
Mitteldorf C; Bertsch HP; Baumgart M; Haase D; Wulf G; Schön MP; Rosenwald A; Neumann C; Kaune KM
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1225-9. PubMed ID: 21923812
[TBL] [Abstract][Full Text] [Related]
6. Case of blastic plasmacytoid dendritic cell neoplasm.
Aoi J; Ogata A; Makino T; Sakai K; Masuguchi S; Fukushima S; Jinnin M; Inoue Y; Ihn H
J Dermatol; 2012 Dec; 39(12):1066-7. PubMed ID: 22970734
[No Abstract] [Full Text] [Related]
7. A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm.
Falcone U; Sibai H; Deotare U
Crit Rev Oncol Hematol; 2016 Nov; 107():156-162. PubMed ID: 27823644
[TBL] [Abstract][Full Text] [Related]
8. Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature.
Liao C; Hu NX; Song H; Zhang JY; Shen DY; Xu XJ; Tang YM
Int J Hematol; 2021 May; 113(5):751-759. PubMed ID: 33392975
[TBL] [Abstract][Full Text] [Related]
9. Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark.
Taylor J; Haddadin M; Upadhyay VA; Grussie E; Mehta-Shah N; Brunner AM; Louissaint A; Lovitch SB; Dogan A; Fathi AT; Stone RM; Tallman MS; Rampal RK; Neuberg DS; Stevenson KE; Horwitz SM; Lane AA
Blood; 2019 Aug; 134(8):678-687. PubMed ID: 31243042
[TBL] [Abstract][Full Text] [Related]
10. Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review.
Wang Q; Zhao Y; Zang X; Zhou G; Liu Y; Feng Q; Li X; Wang W; Dong X; Liu X; Peng J; Liu C
Ann Hematol; 2024 Mar; 103(3):999-1005. PubMed ID: 38285081
[TBL] [Abstract][Full Text] [Related]
11. Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations.
Pemmaraju N; Madanat YF; Rizzieri D; Fazal S; Rampal R; Mannis G; Wang ES; Foran J; Lane AA
Leuk Lymphoma; 2024 May; 65(5):548-559. PubMed ID: 38391126
[TBL] [Abstract][Full Text] [Related]
12. Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm.
Lee SS; McCue D; Pemmaraju N
Expert Rev Anticancer Ther; 2020 Jul; 20(7):543-550. PubMed ID: 32460559
[TBL] [Abstract][Full Text] [Related]
13. Two rare cases of blastic plasmacytoid dendritic cell neoplasm and a literature review.
Chu G; Verner E; Lee K; Painter V; Fletcher J; Curnow J
Leuk Lymphoma; 2014 Oct; 55(10):2405-7. PubMed ID: 24432892
[No Abstract] [Full Text] [Related]
14. Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation--a single center experience.
Heinicke T; Hütten H; Kalinski T; Franke I; Bonnekoh B; Fischer T
Ann Hematol; 2015 Feb; 94(2):283-7. PubMed ID: 25138222
[TBL] [Abstract][Full Text] [Related]
15. Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Alfayez M; Konopleva M; Pemmaraju N
Expert Opin Biol Ther; 2020 Feb; 20(2):115-123. PubMed ID: 31801379
[No Abstract] [Full Text] [Related]
16. A Very Rare Type of Leukemia in a Young Pediatric Patient Treated With Hematopoietic Stem Cell Transplantation: Blastic Plasmacytoid Dendritic Cell Neoplasm.
Tekkeşin F; Asarcikli F; Yildirim ÜM; Zemheri IE; Kiliç SÇ
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e288-e291. PubMed ID: 33235146
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review.
Wang Y; Xiao L; Yin L; Zhou L; Deng Y; Deng H
Medicine (Baltimore); 2023 Feb; 102(7):e32904. PubMed ID: 36800625
[TBL] [Abstract][Full Text] [Related]
18. Blastic Plasmacytoid Dendritic Cell Neoplasm: Underlining the importance of an early diagnosis and the use of tagraxofusp therapy before wide dissemination.
Massone C; Raiola AM; Dominietto A; Minetto P; Beltramini S; Cerroni L; Sola S; Angelucci E
Australas J Dermatol; 2021 May; 62(2):e316-e318. PubMed ID: 32757292
[No Abstract] [Full Text] [Related]
19. A misdiagnosed case of blastic plasmacytoid dendritic cell neoplasm experiencing multiple recurrences who underwent allogeneic stem cell transplantation: a case report.
Salemi F; Mortazavizadeh SMR; Mirmoeeni S; Azari Jafari A; Kosari F; Naghibi Irvani SS
J Med Case Rep; 2021 May; 15(1):292. PubMed ID: 34022952
[TBL] [Abstract][Full Text] [Related]
20. Blastic plasmacytoid dendritic cell neoplasm with response to pralatrexate.
Sato S; Tanaka E; Tamai Y
Ann Hematol; 2019 Mar; 98(3):801-803. PubMed ID: 30652209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
